EMD-19525

Single-particle
3.5 Å
EMD-19525
3D View Gallery
Deposition: 01/02/2024
Map released: 04/09/2024
Last modified: 30/10/2024
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-19525

Archive Files (Depositor)

Primary 3D volume (map.gz) Half-map 1 Half-map 2 (map.gz) Experimental metadata (xml) Experimental metadata (cif.gz)

Validation (wwPDB)

Map-only validation report (pdf.gz) Map-8rvn summary report (pdf.gz) Map-8rvn FULL report (pdf.gz)

EMDB Annotations

EMICSS entry mapping (xml)

EMDB Files

VA raw map (map) VA resolution mask (mrc)

Nipah virus (NiV) fusion protein in complex with neutralizing Fab92

EMD-19525

Single-particle
3.5 Å
EMD-19525
3D View Gallery
Deposition: 01/02/2024
Map released: 04/09/2024
Last modified: 30/10/2024
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Henipavirus nipahense, Oryctolagus cuniculus
Sample: Nipah virus fusion (F) glycoprotein in complex with Fab92
Fitted models: 8rvn

Deposition Authors: Avanzato VA , Stass R, Duyvesteyn HME, Bowden TA
A monoclonal antibody targeting the Nipah virus fusion glycoprotein apex imparts protection from disease.
Avanzato VA , Bushmaker T, Oguntuyo KY, Yinda CK , Duyvesteyn HME, Stass R, Meade-White K, Rosenke R, Thomas T, van Doremalen N, Saturday G, Doores KJ , Lee B , Bowden TA , Munster VJ
(2024) J Virol , 98 , e0063824 - e0063824
PUBMED: 39240113
DOI: doi:10.1128/jvi.00638-24
ISSN: 1098-5514
ASTM: JOVIAM
Grant Support: